MA34332B1 - Procédé pour la préparation de pleuromutilines - Google Patents
Procédé pour la préparation de pleuromutilinesInfo
- Publication number
- MA34332B1 MA34332B1 MA35484A MA35484A MA34332B1 MA 34332 B1 MA34332 B1 MA 34332B1 MA 35484 A MA35484 A MA 35484A MA 35484 A MA35484 A MA 35484A MA 34332 B1 MA34332 B1 MA 34332B1
- Authority
- MA
- Morocco
- Prior art keywords
- formula
- compound
- preparation
- pleuromutilines
- intermediates
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 abstract 8
- 239000000543 intermediate Substances 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 125000003277 amino group Chemical group 0.000 abstract 1
- 238000010511 deprotection reaction Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000011541 reaction mixture Substances 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/40—Y being a hydrogen or a carbon atom
- C07C323/41—Y being a hydrogen or an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/23—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C323/39—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
- C07C323/43—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/52—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C53/00—Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
- C07C53/08—Acetic acid
- C07C53/10—Salts thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
- C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
- C07C57/13—Dicarboxylic acids
- C07C57/145—Maleic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/01—Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
- C07C59/08—Lactic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/56—Ring systems containing bridged rings
- C07C2603/58—Ring systems containing bridged rings containing three rings
- C07C2603/76—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
- C07C2603/80—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
- C07C2603/82—Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
L'invention porte sur un procédé pour la préparation d'un composé de formule I sous la forme d'un seul stéréoisomère sous forme cristalline, comprenant la déprotection du groupe amine dans un composé de formule IIa ou dans un mélange d'un composé de formule IIa avec un composé de formule IIb et la séparation d'un composé de formule I du mélange réactionnel ; sur des composés et sels de composés de formule I sous forme cristalline ; sur des compositions pharmaceutiques comprenant de tels sels ; sur des procédés pour la préparation d'intermédiaires ; et sur des intermédiaires dans un procédé pour la préparation d'un composé de formule I.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP20100450092 EP2399904A1 (fr) | 2010-05-26 | 2010-05-26 | Procédé de préparation de pleuromutilines |
| PCT/AT2011/000237 WO2011146954A1 (fr) | 2010-05-26 | 2011-05-23 | Procédé pour la préparation de pleuromutilines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA34332B1 true MA34332B1 (fr) | 2013-06-01 |
Family
ID=42937801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA35484A MA34332B1 (fr) | 2010-05-26 | 2011-05-23 | Procédé pour la préparation de pleuromutilines |
Country Status (29)
| Country | Link |
|---|---|
| US (1) | US9120727B2 (fr) |
| EP (3) | EP2399904A1 (fr) |
| JP (2) | JP6038021B2 (fr) |
| KR (1) | KR101935333B1 (fr) |
| CN (2) | CN105111117A (fr) |
| AU (1) | AU2011257938B2 (fr) |
| BR (1) | BR112012029982A2 (fr) |
| CA (1) | CA2799029C (fr) |
| DK (2) | DK3299356T3 (fr) |
| EA (1) | EA023273B1 (fr) |
| ES (2) | ES2909198T3 (fr) |
| HR (1) | HRP20220201T1 (fr) |
| HU (2) | HUE057587T2 (fr) |
| IL (1) | IL222999A (fr) |
| MA (1) | MA34332B1 (fr) |
| MX (1) | MX347176B (fr) |
| MY (1) | MY164666A (fr) |
| NZ (1) | NZ603804A (fr) |
| PH (1) | PH12012502321A1 (fr) |
| PL (2) | PL2576505T3 (fr) |
| PT (2) | PT3299356T (fr) |
| SG (1) | SG185104A1 (fr) |
| SI (1) | SI3299356T1 (fr) |
| TN (1) | TN2012000506A1 (fr) |
| TR (1) | TR201802636T4 (fr) |
| TW (1) | TWI585073B (fr) |
| UA (1) | UA108378C2 (fr) |
| WO (1) | WO2011146954A1 (fr) |
| ZA (1) | ZA201208056B (fr) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104447294A (zh) * | 2014-11-24 | 2015-03-25 | 苏州乔纳森新材料科技有限公司 | 一种3-环己烯-1-甲酸的手性拆分方法 |
| BR112017026904B1 (pt) * | 2015-06-17 | 2023-10-10 | Nabriva Therapeutics GmbH | Formulações farmacêuticas injetáveis de lefamulina, e seu uso |
| ES2671160T3 (es) | 2015-06-18 | 2018-06-05 | Mithra Pharmaceuticals S.A. | Unidad de dosificación orodispersable que contiene un componente estetrol |
| LT3701944T (lt) | 2015-06-18 | 2022-04-11 | Estetra Srl | Burnoje disperguojamas dozavimo vienetas, kurio sudėtyje yra estetrolio komponentas |
| TWI762573B (zh) * | 2017-02-10 | 2022-05-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素之純化 |
| CN107417586A (zh) * | 2017-06-21 | 2017-12-01 | 华南农业大学 | 一种截短侧耳素类抗生素及其制备方法和应用 |
| SG11202009725XA (en) | 2018-04-19 | 2020-11-27 | Estetra Sprl | Compounds and their uses for alleviating menopause-associated symptoms |
| TWI801561B (zh) | 2018-04-19 | 2023-05-11 | 比利時商依思特拉私人有限責任公司 | 化合物及其用於緩解絕經相關症狀的用途 |
| TWI755055B (zh) | 2019-09-18 | 2022-02-11 | 台灣神隆股份有限公司 | 用於製備惡拉戈利鈉及其中間體的方法 |
| CN111170893B (zh) * | 2020-01-19 | 2022-04-26 | 郑州依米花手性药物研究有限公司 | Lefamulin的中间体化合物及其在Lefamulin制备中的应用 |
| TWI893101B (zh) | 2020-04-16 | 2025-08-11 | 比利時商埃斯特拉有限責任公司 | 具有降低之副作用之避孕組成物 |
| BR112022020007A2 (pt) * | 2020-04-17 | 2022-11-22 | Nabriva Therapeutics GmbH | Uso terapêutico de pleuromutilinas |
| TW202203907A (zh) * | 2020-04-17 | 2022-02-01 | 奧地利商納畢瓦治療有限責任公司 | 截短側耳素類的新醫療用途 |
| US20250134844A1 (en) | 2022-02-09 | 2025-05-01 | Nabriva Therapeutics GmbH | Therapeutic use of pleuromutilins |
| EP4338732A1 (fr) | 2022-09-16 | 2024-03-20 | Nabriva Therapeutics GMBH | Lefamulin et ses dérivés pour leur utilisation dans le traitement de la tularémie |
| CN118894800A (zh) * | 2024-06-27 | 2024-11-05 | 福建省微生物研究所 | 一种Lefamulin中间体化合物的制备方法 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61207370A (ja) * | 1985-03-11 | 1986-09-13 | Seitetsu Kagaku Co Ltd | ４−（メタンスルホニルオキシ）チオフエノ−ルの製法 |
| GB0017031D0 (en) * | 2000-07-11 | 2000-08-30 | Biochemie Gmbh | Antimicrobials |
| MXPA05000984A (es) * | 2002-07-24 | 2005-09-12 | Sandoz Ag | Derivados de pleuromutilina como antimicrobianos. |
| GB0308114D0 (en) * | 2003-04-08 | 2003-05-14 | Glaxo Group Ltd | Novel compounds |
| DK1667960T3 (da) * | 2003-08-04 | 2008-06-09 | Grindeks Jsc | Meldoniumsalte, fremgangsmåde til deres fremstilling og farmaceutisk sammensætning på deres basis |
| NZ575575A (en) * | 2003-08-18 | 2010-04-30 | Lundbeck & Co As H | Succinate and malonate salt of trans-4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament |
| ATE450535T1 (de) * | 2003-09-03 | 2009-12-15 | Glaxo Group Ltd | Neues verfahren zur herstellung von pleuromutilinderivaten |
| JP2009544354A (ja) | 2006-07-20 | 2009-12-17 | ダブリューエムエス・ゲイミング・インコーポレーテッド | 受動的ゲームプレイに基づく特別イベント資格機能（ｆｅａｔｕｒｅ）を有する賭け事ゲーム |
| EP1908750A1 (fr) * | 2006-10-05 | 2008-04-09 | Nabriva Therapeutics Forschungs GmbH | Procédé de préparation des pleuromutilines |
| DE602007003312D1 (de) * | 2007-02-22 | 2009-12-31 | Indena Spa | Verfahren zur Herstellung von (2r,3s)-3-Phenylisoserin-Methylester-Acetatsalz |
| EP1972618A1 (fr) | 2007-03-20 | 2008-09-24 | Nabriva Therapeutics AG | Dérivés de pleuromutilin pour le traitement des maladies médiées par des microbes |
| EP2014645A1 (fr) | 2007-07-13 | 2009-01-14 | Nabriva Therapeutics AG | Dérivés de pleuromutiline et leur application comme agents antimicrobiens |
| EP2159220A1 (fr) * | 2008-09-02 | 2010-03-03 | Nabriva Therapeutics AG | Composés organiques |
-
2010
- 2010-05-26 EP EP20100450092 patent/EP2399904A1/fr not_active Withdrawn
-
2011
- 2011-05-23 SI SI201132039T patent/SI3299356T1/sl unknown
- 2011-05-23 HR HRP20220201TT patent/HRP20220201T1/hr unknown
- 2011-05-23 EA EA201291370A patent/EA023273B1/ru unknown
- 2011-05-23 ES ES17197350T patent/ES2909198T3/es active Active
- 2011-05-23 US US13/699,589 patent/US9120727B2/en active Active
- 2011-05-23 BR BR112012029982-4A patent/BR112012029982A2/pt not_active Application Discontinuation
- 2011-05-23 CA CA2799029A patent/CA2799029C/fr active Active
- 2011-05-23 KR KR1020127030731A patent/KR101935333B1/ko active Active
- 2011-05-23 JP JP2013511476A patent/JP6038021B2/ja active Active
- 2011-05-23 EP EP11724938.3A patent/EP2576505B1/fr active Active
- 2011-05-23 HU HUE17197350A patent/HUE057587T2/hu unknown
- 2011-05-23 MY MYPI2012700960A patent/MY164666A/en unknown
- 2011-05-23 PT PT171973506T patent/PT3299356T/pt unknown
- 2011-05-23 TR TR2018/02636T patent/TR201802636T4/tr unknown
- 2011-05-23 ES ES11724938.3T patent/ES2659729T3/es active Active
- 2011-05-23 UA UAA201214910A patent/UA108378C2/ru unknown
- 2011-05-23 DK DK17197350.6T patent/DK3299356T3/da active
- 2011-05-23 MX MX2012013645A patent/MX347176B/es active IP Right Grant
- 2011-05-23 MA MA35484A patent/MA34332B1/fr unknown
- 2011-05-23 CN CN201510488095.0A patent/CN105111117A/zh active Pending
- 2011-05-23 PL PL11724938T patent/PL2576505T3/pl unknown
- 2011-05-23 CN CN201180036554.1A patent/CN103080083B/zh active Active
- 2011-05-23 DK DK11724938.3T patent/DK2576505T3/en active
- 2011-05-23 PT PT117249383T patent/PT2576505T/pt unknown
- 2011-05-23 PL PL17197350T patent/PL3299356T3/pl unknown
- 2011-05-23 AU AU2011257938A patent/AU2011257938B2/en active Active
- 2011-05-23 PH PH1/2012/502321A patent/PH12012502321A1/en unknown
- 2011-05-23 NZ NZ603804A patent/NZ603804A/en unknown
- 2011-05-23 EP EP17197350.6A patent/EP3299356B1/fr active Active
- 2011-05-23 WO PCT/AT2011/000237 patent/WO2011146954A1/fr not_active Ceased
- 2011-05-23 TW TW100117950A patent/TWI585073B/zh not_active IP Right Cessation
- 2011-05-23 SG SG2012080339A patent/SG185104A1/en unknown
- 2011-05-23 HU HUE11724938A patent/HUE035861T2/hu unknown
-
2012
- 2012-10-23 TN TNP2012000506A patent/TN2012000506A1/en unknown
- 2012-10-25 ZA ZA2012/08056A patent/ZA201208056B/en unknown
- 2012-11-12 IL IL222999A patent/IL222999A/en active IP Right Grant
-
2016
- 2016-09-08 JP JP2016175859A patent/JP6501742B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA34332B1 (fr) | Procédé pour la préparation de pleuromutilines | |
| MA35128B1 (fr) | Nouveaux dérivés d'imidazole utiles pour le traitement de l'arthrite | |
| MX2009013733A (es) | Nuevos derivados de acido dicarboxilico como agonistas de los receptores de s1p1. | |
| MA31311B1 (fr) | Dérivés d'indazole substitués par oxadiazole, destinés à être utilisés comme agonistes de la sphingosine 1-phosphate (s1p) | |
| MA33840B1 (fr) | Nouveau composé de spiropipéridine | |
| MA32965B1 (fr) | Derives de sulfonamides | |
| MA32104B1 (fr) | Dérivés d'oxime en tant qu'inhibiteurs de hsp90 | |
| TN2009000450A1 (fr) | Derives de pyridine | |
| MA31754B1 (fr) | Cis-imidazolines chirales | |
| MA33642B1 (fr) | Composés chimiques | |
| MY158339A (en) | DIAMIDE COMPOUNDS HAVING MUSCARING RECEPTOR ANTAGONIST AND ß2 ADRENERGIC RECEPTOR AGONIST ACTIVITY | |
| MA34767B1 (fr) | Compositions et procédés pour la modulation de fxr | |
| MA33662B1 (fr) | Composés de spiropipéridine et leur utilisation pharmaceutique pour le traitement du diabète | |
| MA31593B1 (fr) | Derives de 2-aza-bicyclo[3.3.0]octane | |
| EP4328223A3 (fr) | Diaminocarboxamidepyrimidines et diaminocarbonitrilepyrimidines substituées, compositions de celles-ci et procédés de traitement à l'aide de celles-ci | |
| MA35826B1 (fr) | Triazolopyridines substituées et leur utilisation à titre d'inhibiteurs de ttk | |
| MA34308B1 (fr) | Triazolopyridines substituées | |
| WO2010024930A3 (fr) | Analogues de cortistatine et leurs synthèses | |
| MA29839B1 (fr) | Derives de carboxamides servant d'antagonistes des recepteurs muscariniques | |
| MA34957B1 (fr) | Derives heteroaryle a titre modulateurs des nachr alpha 7 | |
| MA31359B1 (fr) | Pyrimidinyl-pipérazines utiles en tant que ligands des récepteurs d3/d2 | |
| MA34982B1 (fr) | Synthese de derives de 2-carboxamidocycloaminouree | |
| MX2009008324A (es) | Compuestos 6´-sustituidos que tienen afinidad con el receptor de 5-hidroxitriptamina-6. | |
| MA31863B1 (fr) | Dérivés de pyrazole comme inhibiteurs de 5-lo | |
| WO2009076408A3 (fr) | Dérivés de 3-carboxypropyl-aminotétraline et composés associés en tant qu'antagonistes du récepteurs mu-opioïde |